EFDID: 495926EFD: View Filing

Issuer: Olema Pharmaceuticals, Inc. (0001750284) - D

Accession: 0001243233-23-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001750284
  • Entity Name:
    Olema Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    780 BRANNAN STREET
    SAN FRANCISCO, CA 94103
  • Persons:
    Related Persons 12
    Sean Bohen, M.D., Ph.D.
    Executive Officer, Director
    David C. Myles, Ph.D.
    Executive Officer
    Shane Kovacs
    Executive Officer
    Naseem Zojwalla, M.D.
    Executive Officer
    Yi Larson
    Director
    Andrew Rappaport
    Director
    Cynthia Butitta
    Director
    Cyrus L. Harmon, Ph.D.
    Director
    Sandra Horning, M.D.
    Director
    Gorjan Hrustanovic, Ph.D.
    Director
    Graham Walmsley, M.D., Ph.D.
    Director
    Ian Clark
    Director
EDGAR: Offering Information
  • Accession Date:
    09/14/2023
  • First Sale Date:
    09/05/2023
  • Offering Amount:
    $130,000,000
  • Amount Sold:
    $130,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, MA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Olema Pharmaceuticals, Inc./s/ Shane KovacsShane KovacsEVP, Chief Legal Officer and Secretary2023-09-13